back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-09 16:58 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,599
+55,000 vol $2.32 each |
340,000 | |
| Filed 2026-08-31 17:13 Tx date 2026-08-28 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$37,016
+17,627 vol $2.10 each |
17,627 | |
| Filed 2026-08-31 17:12 Tx date 2021-09-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-31 17:09 Tx date 2026-08-28 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-105,000
-50,000 vol $2.10 each |
285,000 | |
| Filed 2026-04-08 15:25 Tx date 2026-04-02 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,150
-5,000 vol $4.23 each |
37,758 | |
| Filed 2026-04-08 15:24 Tx date 2026-04-08 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,914
-10,000 vol $4.19 each |
27,758 | |
| Filed 2026-03-13 11:48 Tx date 2026-03-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,924
-5,000 vol $3.98 each |
42,758 | |
| Filed 2026-03-02 11:04 Tx date 2026-02-26 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,514
-5,000 vol $4.10 each |
57,758 | |
| Filed 2026-03-02 11:03 Tx date 2026-02-26 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,639
-5,000 vol $4.13 each |
62,758 | |
| Filed 2026-03-02 11:00 Tx date 2026-03-02 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,517
-10,000 vol $3.85 each |
47,758 | |
| Filed 2026-02-23 12:36 Tx date 2026-02-20 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,914
-9,980 vol $4.30 each |
67,758 | |
| Filed 2026-02-23 12:35 Tx date 2026-02-19 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86.00
-20 vol $4.30 each |
77,738 | |
| Filed 2026-02-23 12:34 Tx date 2026-02-19 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,773
-10,000 vol $4.18 each |
77,758 | |
| Filed 2026-02-23 12:33 Tx date 2026-02-18 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,312
-10,000 vol $4.13 each |
87,758 | |
| Filed 2026-02-16 13:05 Tx date 2026-02-12 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,958
-10,000 vol $4.00 each |
97,758 | |
| Filed 2025-12-09 13:57 Tx date 2024-01-08 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,977
+2,000 vol $1.99 each |
2,000 | |
| Filed 2025-12-09 13:55 Tx date 2024-01-08 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,977
+2,000 vol $1.99 each |
||
| Filed 2025-12-09 13:30 Tx date 2025-12-04 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$212,000
+100,000 vol $2.12 each |
107,758 | |
| Filed 2025-12-09 13:23 Tx date 2025-12-04 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Holder: Fig Advisory LLC (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-212,000
-100,000 vol $2.12 each |
0 | |
| Filed 2024-01-15 15:18 Tx date 2024-01-08 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,977
+2,000 vol $1.99 each |